Status:
COMPLETED
Study Examines the Feasibility, Safety and Benefits of Using a Specific Suspension Walking Device for Patients With Neurological Damage
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Stroke
Traumatic Brain Injury
Eligibility:
All Genders
18+ years
Brief Summary
This monocentric descriptive study addresses feasibility, safety and benefits of using a specific suspension walking device for patients with severe neurological injuries in the neuroICU of Montpellie...
Detailed Description
Background. Current literature and National guidelines recommend early mobilization in Intensive Care Units (ICU), including verticalization and walking. Verticalization for neurologic patients in ICU...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adults
- Severe Neurological injury
- Hospitalization \> 48h in a unique Neuro-ICU
- Necessity of mechanical ventilation
- Exclusion criteria:
- death before sedation weaning
- therapeutic limitation
- complete spinal cord injury
Exclusion
Key Trial Info
Start Date :
March 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04300491
Start Date
March 30 2020
End Date
April 30 2020
Last Update
June 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295